Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$35.48 - $67.33 $12,524 - $23,767
-353 Closed
0 $0
Q3 2021

Nov 08, 2021

SELL
$61.0 - $81.99 $123,159 - $165,537
-2,019 Reduced 85.12%
353 $23,000
Q2 2021

Aug 09, 2021

BUY
$62.93 - $90.59 $9,439 - $13,588
150 Added 6.75%
2,372 $185,000
Q1 2021

Apr 28, 2021

BUY
$88.19 - $140.01 $195,958 - $311,102
2,222 New
2,222 $210,000
Q4 2020

Feb 09, 2021

SELL
$87.69 - $130.94 $138,024 - $206,099
-1,574 Closed
0 $0
Q3 2020

Nov 02, 2020

BUY
$56.99 - $89.33 $45,705 - $71,642
802 Added 103.89%
1,574 $138,000
Q2 2020

Aug 11, 2020

BUY
$39.94 - $70.39 $30,833 - $54,341
772 New
772 $51,000

About Turning Point Therapeutics, Inc.


  • Ticker TPTX
  • Exchange NASDAQ
  • Shares Outstandng 50,074,300
More about TPTX
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.